Inventor · disambiguated record
Jay Bradford Fell
Also filed as: FELL JAY B · FELL JAY BRADFORD
22 granted patents·16 pending applications·123 citations·filing 2005–2025
94Inventor score
Files withMIRATI THERAPEUTICS INC15ARRAY BIOPHARMA INC11AICHER THOMAS DANIEL4COGENT BIOSCIENCES INC4ROCHE PALO ALTO LLC3
Top patents by PatentIndex Score
38 records- 0197US10689377B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2018·Granted Jun 23, 2020·16 cites·57 claims
- 0296US11453683B1KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·13 cites·84 claims
- 0396US10125134B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2017·Granted Nov 13, 2018·43 cites·9 claims
- 0493US10633381B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2018·Granted Apr 28, 2020·8 cites·7 claims
- 0592US11964989B2KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·2 cites·19 claims
- 0691US11267812B2KRAS G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2017·Granted Mar 8, 2022·11 cites·34 claims
- 0789US11634417B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Apr 25, 2023·2 cites·52 claims
- 0889US10730880B24,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Aug 4, 2020·4 cites·25 claims
- 0989US7674810B21,1-dioxo-1H-1Λ6-benzo[d]isothiazol-3-yl)-4-hydroxy-1,5-dihydro-pyrrol-2-one inhibitors of HCV polymeraseROCHE PALO ALTO LLC·Filed 2006·Granted Mar 9, 2010·8 cites·15 claims
- 1087US7479489B2Heterocyclic antiviral compoundsROCHE PALO ALTO LLC·Filed 2005·Granted Jan 20, 2009·7 cites·41 claims
- 1182US2024101553A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1281US11932633B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2019·Granted Mar 19, 2024·2 cites·41 claims
- 1381US8212045B2Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2008·Granted Jul 3, 2012·4 cites·9 claims
- 1479US2024124453A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1578US10189845B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Jan 29, 2019·2 cites·20 claims
- 1678US2023373999A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1777US2024309020A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1876US2025066357A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1974US11884664B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2022·Granted Jan 30, 2024·0 cites·16 claims
- 2069US8853409B2Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2012·Granted Oct 7, 2014·1 cites·32 claims
- 2168US12351581B2Compounds for FGFR inhibitionCOGENT BIOSCIENCES INC·Filed 2024·Granted Jul 8, 2025·0 cites·30 claims
- 2264US11028093B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Jun 8, 2021·0 cites·19 claims
- 2363US12187721B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Jan 7, 2025·0 cites·22 claims
- 2460US9079890B2Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivativesARRAY BIOPHARMA INC·Filed 2014·Granted Jul 14, 2015·0 cites·12 claims
- 2558US2025270211A1Compounds for fgfr inhibitionCOGENT BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2657US2024034733A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2756US2024270741A1Compounds for fgfrs inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2855US2023357277A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2954US2023339976A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3053US2025129078A1Erbb2 inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 3153US2023279025A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3247US7531534B2Heterocyclic antiviral compoundsROCHE PALO ALTO LLC·Filed 2007·Granted May 12, 2009·0 cites·15 claims
- 3347US2021230170A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3442US2014309226A1Piperidinyl-substituted cyclic ureas as gpr119 modulatorsARRAY BIOPHARMA INC·Filed 2012·Application pending·0 cites
- 3541US2014256756A1Piperidinyl-substituted lactams as gpr119 modulatorsARRAY BIOPHARMA INC·Filed 2012·Application pending·0 cites
- 3638US2013184257A1Piperidinyl-substituted lactams as gpr119 modulatorsAICHER THOMAS DANIEL·Filed 2011·Application pending·0 cites
- 3737US8754226B2Piperidinyl-substituted lactams as GPR119 modulatorsAICHER THOMAS DANIEL·Filed 2011·Granted Jun 17, 2014·0 cites·71 claims
- 3836US8865726B2Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitorsANDREWS STEVEN W·Filed 2010·Granted Oct 21, 2014·0 cites·45 claims
Join the waitlist — get patent alerts
Get an alert when Jay Bradford Fell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →